Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6523390 | 7234921 | I | 6523390-2 | 20091222 | 20091222 | 20091231 | EXP | AT-ROCHE-676233 | ROCHE | 35 | F | Y | 67 | KG | 20091231 | MD | AUSTRIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6523390 | 1012885611 | PS | PEG-INTERFERON ALFA 2A (RO 25-8310) | 2 | SUBCUTANEOUS | LAST DOSE PRIOR TO SAE: 15 DEC 2009, FORM AS PER PROTOCOL. | |||||
| 6523390 | 1012885612 | SS | RIBAVIRIN | 1 | ORAL | LAST DOSE PRIOR TO SAE 15 DEC 2009, FORM AS PER PROTOCOL. | 021511 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6523390 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6523390 | CONJUNCTIVITIS VIRAL |
| 6523390 | PROTHROMBIN TIME PROLONGED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6523390 | 1012885611 | 20091215 |